Amanda Ebbutt, partner, and Paul England, senior counsel – knowledge at Taylor Wessing.

10 June 2025FeaturesEuropeAmanda Ebbutt & Paul England

Three reasons why the UK should reconsider joining the UPC

Two years since the UPC opened its doors, various developments might influence the UK government to reassess its position, write Amanda Ebbutt and Paul England of Taylor Wessing.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Europe

Final call: Who are the world’s best in-house counsel?

16 January 2026 A first-of-its-kind project by sister title WIPR aims to highlight the world’s leading in-house intellectual property counsel—and it needs your help.

Europe

Italian medtech startup beats larger US rival in UPC dispute

15 January 2026 Case between AorticLab and Emboline has implications for UPC playbook in terms of requesting security for costs, and conditional counterclaims.

Europe

Bayer secures key Denmark ruling as Xarelto faces expiry pressure

13 January 2026 As the drug moves deeper into its post-exclusivity phase, a Nordic decision highlights the value of secondary patents, presumption of validity, and interim relief when a drug's core patents expire.

More features

Rooted in rights: Lessons from plant patent infringement and invalidity cases

$5.4bn medtech leader fails to bury a rival's patent

Final call: Who are the world’s best in-house counsel?

Italian medtech startup beats larger US rival in UPC dispute

Goodwin targets transatlantic patent work with London hire

Bayer secures key Denmark ruling as Xarelto faces expiry pressure

Carpmaels & Ransford builds Munich UPC team with elite hire

Why the US is poised for a patent litigation surge in 2026

Three reasons why the UK should reconsider joining the UPC

More on this story

Editor's picks

Editor's picks

More features